Rare diseases
Investigational molecules
Locations
Back to France1 745 clinical trials in Roubaix, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid
FranceLong-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations
FranceStudy on the Effects of Latozinemab for Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations
FranceStudy on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas
FranceStudy on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy on Obinutuzumab, Venetoclax, and Ibrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma
FranceStudy of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations
FranceStudy of INBRX-109 (ozekibart) compared to placebo in adults with unresectable or metastatic chondrosarcoma - a rare bone cancer
FranceStudy Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant
FranceStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
FranceStudy of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors
FranceThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for Multiple Myeloma and various forms of leukemia, including comparative studies of novel therapeutic combinations and traditional approaches.
Studies evaluating treatment effectiveness in newly diagnosed patients and those with advanced disease stages.
Innovative research exploring potential treatments for Alzheimer's disease, including studies on caffeine's effects on cognitive function in early-to-moderate stage patients.
Focus on non-pharmacological interventions and their impact on disease progression.
Clinical investigations into severe asthma management and pulmonary infections, including studies on treatment optimization and novel therapeutic approaches.
Evaluation of long-term treatment strategies and comparative medication studies.
Research examining hypertension management in patients with chronic kidney disease, along with studies on thrombo-embolic complications prevention.
Focus on optimizing treatment strategies for complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
